惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

博客园_首页
Security Archives - TechRepublic
Security Archives - TechRepublic
Application and Cybersecurity Blog
Application and Cybersecurity Blog
cs.CV updates on arXiv.org
cs.CV updates on arXiv.org
C
CERT Recently Published Vulnerability Notes
S
Security @ Cisco Blogs
S
Security Affairs
D
Darknet – Hacking Tools, Hacker News & Cyber Security
L
Lohrmann on Cybersecurity
cs.AI updates on arXiv.org
cs.AI updates on arXiv.org
Hacker News: Ask HN
Hacker News: Ask HN
Forbes - Security
Forbes - Security
H
Heimdal Security Blog
A
Arctic Wolf
NISL@THU
NISL@THU
P
Proofpoint News Feed
W
WeLiveSecurity
S
Schneier on Security
AI
AI
Schneier on Security
Schneier on Security
N
News and Events Feed by Topic
L
LINUX DO - 最新话题
Cisco Talos Blog
Cisco Talos Blog
AWS News Blog
AWS News Blog
Hacker News - Newest:
Hacker News - Newest: "LLM"
Know Your Adversary
Know Your Adversary
Scott Helme
Scott Helme
V
Vulnerabilities – Threatpost
Cyberwarzone
Cyberwarzone
I
Intezer
S
Securelist
Help Net Security
Help Net Security
Microsoft Security Blog
Microsoft Security Blog
量子位
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
小众软件
小众软件
Last Week in AI
Last Week in AI
Jina AI
Jina AI
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
WordPress大学
WordPress大学
罗磊的独立博客
月光博客
月光博客
雷峰网
雷峰网
A
About on SuperTechFans
The GitHub Blog
The GitHub Blog
T
The Blog of Author Tim Ferriss
MongoDB | Blog
MongoDB | Blog
大猫的无限游戏
大猫的无限游戏
博客园 - 司徒正美
CTFtime.org: upcoming CTF events
CTFtime.org: upcoming CTF events

Forbes - Healthcare

The Trump Administration Is Shifting Federal Policy On Cannabis And Psychedelics How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health Doctors Say Hegseth’s Flu Vaccine Decision Will Weaken Military Readiness Where Bullets Fly, Malaria Kills Using AI To Personalize Healthcare–Without Losing Patient Trust Progress For Preeclampsia Allowing Our Military To Refuse Flu Vaccination Is A Bad Idea. Here’s Why Can Vaccine Development Weather Political Storms? A Virus From Farmed Seafood Is Causing A New Eye Disease In People Elevance Health Profits Eclipse $1.7 Billion Despite Elevated Costs The UK Passes A Lifetime Smoking Ban. Could America Be Next? There's No Such Thing As Brain Honey UnitedHealth Group Profits Eclipse $6 Billion As Medical Costs Ease AI Is Already Here. The Real Risk In Public Health Is Sitting It Out UnitedHealthcare Reduces Need For Prior Approvals For Patients In Rural America Why No Child Should Have To Sacrifice School To Care For Their Family Oscar Health Launches Consumer Marketplace For Insurance Beyond Its Own Calling The Iconic 867-5309 Now Goes To A Cancer Helpline FDA Lists Xanax Recall. Here’s What You Need To Know What Trump’s Ibogaine Executive Order Means For Veterans With PTSD 20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs Rotavirus Is Surging Across The US — Here’s What Parents Need To Know Leadership Dysfunctional In Healthcare: “Split The Baby” Thinking ‘Bedtime Stacking’ Trends On TikTok. Here Are The Risks Why Do Weight Loss Drugs Work For Some And Not Others? It’s In The Genes Hospital Safety: How to Avoid Medical Errors and Protect Yourself Medicare Can Save $4 Billion On Four Cancer Drugs — Can You Guess Which Ones? After 25 Years Of Consumer-Directed Healthcare, What’s Missing? This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster RFK Jr. Pushes To Expand Access To Peptides. A Doctor Explains The Risks How The Trump Administration Is Blocking Access To Home Care Genome Sequencing Solves Rare Disease Mysteries Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most New Drug Protects Against Life-Threatening Pancreatitis This Pill May Help Pancreatic Cancer Patients Live Longer What Should We Do When The Patient Is Racist? Attention Turns To UnitedHealth Earnings For Signs Of Insurer Rebound New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know Why Sex Exists A Novel Approach To The Treatment Of Antibiotic Resistant Infections Democrat-Leaning Plan Takes Aim At Health Plans With New Regulations Trump Administration Weighs Default Medicare Advantage Plans For Seniors An AI System Passed Peer Review. The Scientific Community Isn’t Ready Prior Authorization Reform Is Here — And It Could Change How Millions Get Care The More We Add To U.S. Healthcare, The Worse It Gets How Two Sisters Built A $1 Billion HealthTech Unicorn CDC Delays Reporting Of COVID-19 Vaccine Benefits—Here’s What To Know This Startup Wants To Use AI To Help Digitize History Are Nicotine Pouches Like Zyn And VELO Safe To Use? A Doctor Answers America’s Healthcare Innovation Problem GLP-1 Weight Loss Drugs Are Easy To Get—But Are They Safe? Why Cleveland Clinic Chose This AI Startup To Rewire Key Healthcare Operations Upset About The High Price Of Your Hospital Stay? Medicaid Cuts Might Be To Blame Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest A New Way To Target Metastatic Cancer What A Florida Birth Case Reveals About Post-Dobbs Maternal Healthcare 5 Reasons Why the Medicare Program Can’t Go Broke Lowering Healthcare Costs Without A Disastrous Government-Run Model Promising Study Links Coffee Consumption To Reduced Dementia Risk Gene Regulation May Control How Long We Live Health Insurers Get 2.5% Medicare Rate Hike They Feared Would Be Flat Engineered Antibodies Pry Apart The Most Difficult Viruses 1.6 Million Teens Are Vaping. Health Risks Are Worse Than You Think Increasing Burdens Medical Debt And Bankruptcy Are Uniquely American Medicaid Work Requirements Go Live Soon. Here’s How Many Could Lose Coverage What SpaceX’s IPO Means For The Space Economy Thus Far, Most Favored Nation Drug Prices Have Had Little Impact FDA Approves New Oral Weight Loss Pill Foundayo — Here’s What To Know ‘Medicare By Choice’ Plans Could Work, But More Details Needed Criticism of NFL's Rooney Rule Misses How Hiring Actually Works Navigating Health In The Age Of Misinformation NASA Artemis II astronaut health risks explained
Centene Latest Health Insurer To Shakeup Management Ranks
Bruce Japsen · 2026-04-06 · via Forbes - Healthcare
Centene Health Net Acquisition.

Centene is bolstering its management team with two new senior management postions as health insurers battle higher costs and new policies at the federal level. The building housing Centene Corporation headquarters is seen Thursday, July 2, 2015, in Clayton, Mo. (AP Photo/Jeff Roberson)

ASSOCIATED PRESS

Centene is bolstering its management team by creating two new senior executive positions as health insurers battle higher costs and new policies at the federal level.

Like many of its rival health insurers, the company has been battling rising medical expenses from customers in its health plans and its stock price has been hit hard. In Centene’s case, the company is also facing policy changes after the Republican-led Congress and the Donald Trump White House refused to renew enhanced subsidies for millions of Americans who buy individual coverage under the Affordable Care Act, also known as Obamacare.

Centene said Monday it has created two “new executive leadership positions” which will report to company chief executive Sarah London, hiring Daniel Finke as group president, markets and commercial as well as Michael Carson as group president, Medicare and specialty. Both have extensive experience in the health insurance industry, Centene said. Finke’s background includes work as CEO of Convey Health Solutions and a top leadership role at CVS Health’s Aetna, the nation’s third-largest health insurance company.

Meanwhile, Centene said Carson “will have expanded oversight of Centene's Medicare Advantage, Medicare Part D, Duals, and Specialty businesses.” Carson, who joined Centene in January of 2024, was CEO of “Bright Healthcare and Harvard Pilgrim Health Care, as well as CareAbout, a multi-specialty, value-based care delivery organization,” the company said.

"We are pleased to recognize Michael's continued leadership and excited to leverage Dan's deep industry expertise and track record of strategic execution," said Sarah London, Chief Executive Officer of Centene. "Their collective experience will be instrumental as we continue to strengthen performance across the portfolio and deliver sustainable, profitable growth."

Several other health insurers have been bringing in new executives or replacing CEOs in the last two years. Just last week, Elevance Health made several changes to its management ranks at both the health insurance business and its Carelon health services that includes new chief finance officers at each unit.

In February, Centene reported a loss of more than $1 billion in the fourth quarter of last year as the company continued to struggle with rising healthcare costs in the government-subsidized health plans it administers and sells. Centene is seeing rising costs among health plan members in all three government-subsidized benefits it helps manage: Medicaid, Medicare Advantage for older adults and Obamacare.

In addition, Centene said the company’s Obamacare enrollment is down more than 1.5 million from just a few months ago in what many analysts see as a sign Americans can no longer pay for health insurance and are dropping coverage.

London told analysts and investors that the company, which is historically the largest publicly traded provider of Obamacare, was on track for "roughly 3.5 million members by the end of the quarter with still some movement as we work through the grace period in March.”

That’s down from more than 5 million enrollees in Centene’s Ambetter brand plans who purchased coverage on the ACA’s marketplaces for last year. The big dip in Centene’s enrollment is what Democrats in Congress and health insurance industry analysts said would happen after Republicans in Congress and the Donald Trump White House wouldn’t agree to extend enhanced tax credits for buyers of Obamacare.

A KFF analysis last fall said middle income Americans “as well as those with low incomes” will see “major out-of-pocket premium increases" if tax credits aren’t extended. And they are with customers reporting a doubling and even tripling of premiums for this year.

The subsidies, or tax credits, made health insurance premiums more affordable for individuals and were enhanced by the Biden administration and the Democratic-controlled Congress, which passed the Inflation Reduction Act of 2022, allowing more Americans to buy coverage. The enhanced subsidies helped enrollment in the ACA’s individual coverage, also known as Obamacare, eclipse a record 24 million Americans and help its popularity hit all-time highs.

The Trump administration, via the Centers for Medicare & Medicaid Services, said in late January that 23 million consumers “have signed up for 2026 individual market health insurance coverage through the Marketplaces since the start of the 2026 Marketplace Open Enrollment Period on November 1, 2025.”